background: Safety concerns have been expressed regarding the use of immature non-ejaculated spermatozoa for ICSI. Therefore, adverse health outcomes, birth parameters, major anomaly rates and chromosomal aberrations in children born after ICSI using testicular and epididymal sperm were investigated. methods: Questionnaire data and results of physical examinations of 530 children born after ICSI with testicular sperm and of 194 children born after ICSI with epididymal sperm were compared with data on 2516 ICSI children born using ejaculated sperm.
Introduction
Since the introduction of the ICSI technique, azoospermic men can become the genetic fathers of their offspring. Not only the use of ejaculated sperm, but also the use of immature sperm, such as testicular and epididymal sperm, has been introduced into daily routine Tournaye et al., 1994; Nagy et al., 1995) . However, due to the increased aneuploidy rate in spermatozoa from patients with testicular failure (Bernardini et al., 2000; Martin et al., 2000; Levron et al., 2001) , concerns of the increased congenital anomaly rate and chromosomal aberrations in children born after the use of non-ejaculated sperm are pertinent.
Published studies concerning the neonatal outcome of children born after the use of non-ejaculated sperm suffer from methodological shortcomings (Woldringh et al., 2010) . Consequently, firm conclusions on the wellbeing of children born after the use of non-ejaculated sperm are being hampered, due to numerous potential biases. It has been shown that birth parameters of children conceived with non-ejaculated sperm are comparable to those of children conceived after the use of ejaculated sperm (Wennerholm et al., 2000; Ludwig and Katalinic, 2003) . Furthermore, no increased anomaly rate is reported in ICSI children conceived with epididymal or testicular sperm when compared with children conceived with ejaculated sperm (Palermo et al., 2000; Wennerholm et al., 2000; Bonduelle et al., 2002a; Ludwig and Katalinic, 2003; Fedder et al., 2007 , Källén et al., 2010 .
To date, the neonatal health of children born after ICSI using testicular and epididymal spermatozoa is not well documented, mostly due to heterogeneity and small study groups.
Therefore, we analysed the neonatal outcome of 724 live-and stillborns from a consecutive cohort of viable ICSI cycles performed with testicular and epididymal spermatozoa between 1997 and 2004. Part of these data is described in an earlier study from our group (Vernaeve et al., 2003) . Results of the non-ejaculated sperm groups are compared with previously described neonatal data of 2516 ICSI live-and stillborns after the use of ejaculated, non-donated sperm between 1991 and 1999 (Bonduelle et al., 2002a) .
Materials and Methods

Study design
The study set-up was similar to earlier follow-up studies and has been extensively described in previous publications (Bonduelle et al., 2002a,b) . Briefly, data on pregnancies, deliveries and neonatal histories were gathered from questionnaires filled out by parents and gynaecologists. In addition, children were invited for clinical examination at 2 months, 1 year and 2 years of age. Special attention was given to the detection of congenital anomalies.
All viable pregnancies (ongoing after the 20th week of gestation) after transfer of fresh or frozen-thawed embryos between 1994 and 2007 using fresh or frozen testicular and epididymal sperm were included. Cycles that involved the use of donor sperm were excluded.
Technical procedures, including testicular/epididymal sperm retrieval, have been described previously (Verheyen et al., 1995; Tournaye et al., 1997; Joris et al., 1998) .
In a subanalysis of the children born after the use of testicular sperm, outcome parameters were analysed in relation to the cause of their fathers' azoospermia: obstructive azoospermia (OA) due to vasectomy, congenital bilateral absence of the vas deferens, genital tract infection or 'functional obstructive' azoospermia due to anejaculation or nonobstructive azoospermia (NOA) caused by primary testicular dysfunction, histologically being characterized by germ cell aplasia, maturation arrest, sclerosis and atrophy or hypospermatogenesis at histology. The distinction between NOA and OA was made according to testicular histology.
Pre-and post-natal karyotype
Although karyotyping only picks up major chromosomal aberrations, preand post-natally obtained results of live-and stillbirths were given in order to provide a complete overview of the neonatal health of children born using non-ejaculated sperm.
Results of pre-and post-natal karyotyping in children born after the use of non-ejaculated sperm were compared with previously described chromosomal anomalies in 1469 karyotypes in ICSI pregnancies after the use of ejaculated, non-donated sperm and in 252 post-natally obtained karyotypes from children born after the use of ejaculated, non-donated sperm (Bonduelle et al., 2002b) .
Definitions
Gestational age: calculated from the day of oocyte aspiration which was defined as Day 14 of the cycle. Stillbirth: intrauterine or intrapartum death of a child born with a gestational age ≥20 weeks (active terminations after 20th week of gestation were not included). Preterm birth: delivery before 37 completed weeks of gestation. Low birthweight: ,2500 g at birth. Very low birthweight: ,1500 g at birth. Early neonatal death: death of a child before Day 7. Perinatal death: number of stillborns and early neonatal deaths. Pregnancy-induced conditions included gestational diabetes, pregnancy-induced hypertension and pre-eclampsia. Maternal educational level was classified according to a two-level status: higher (i.e. levels equivalent to bachelor or higher university degrees) or lower (i.e. the remaining) educational level.
Identical guidelines and classifications in the study populations were used as extensively described in previous publications (Bonduelle et al., 2002a,b) . A widely accepted definition of major anomalies was used, i.e. anomalies that generally cause functional impairment or require surgical correction. For instance, ductus arteriosus was considered major if still patent at 3 months for a child born at term or at 6 months for a preterm child ≤36 weeks. Inguinal hernia was considered as a major anomaly for a child born after 36 weeks. The total major anomaly rate was computed as (affected live births + affected stillborns + induced abortions for major anomalies) divided by (live births + stillbirths).
Statistics
Continuous data are presented as mean and standard deviation (SD) and analysed by two-way analysis of variance using SPSS version 17.0 (SPSS Inc., Chicago, IL, USA).
Categorical data are presented as the number of children (events) and percentages for each group of interest. Comparisons among groups are presented as odds ratios (ORs) with corresponding 95% confidence intervals (95% CIs) for each comparison made. In doing so, we provide information to the reader on magnitude and precision of the OR for each comparison, as well as the role that chance may play in the observed study results (Altman, 1991) .
Results
Evolution of pregnancies and number of children
Of the 657 pregnancies obtained after ICSI using testicular spermatozoa, 426 (63%) were ongoing after 20 weeks eventually leading to the birth of 530 children: 331 singletons, 178 twins and 21 triplets (Table I) . Three pregnancies were terminated because of Potter syndrome, hydrops fetalis and trisomy 18. Pregnancy outcome according to the sperm origin is described in Supplementary data, Table S1. In the testicular sperm group, 12 babies were stillborn (2.3%) and 5 babies (0.9%) died during the first 7 days. One pair of twins died shortly after their very premature birth (gestational age of 23 weeks), the second pair of twins died due to chorioamnionitis and one singleton died because of a major anomaly (hernia diaphragmatica).
Of the 202 pregnancies obtained after ICSI using epididymal spermatozoa, 150 (75%) were ongoing after 20 weeks, eventually leading to the birth of 194 children: 99 singletons, 67 twins, 24 triplets and 4 quadruplets. In the epididymal group, 12 babies were stillborn (6.2%) and 2 babies (1.1%) died during the first 7 days because of major anomalies (achondroplasia and hernia diaphragmatica).
The stillbirth rate according to multiplicity in the non-ejaculated group was comparable to the rate in the ejaculated sperm group (Table I) . Conversely, the early neonatal death rate was significantly higher for singletons and twins born after the use of non-ejaculated sperm in comparison to children born after the use of ejaculated sperm. The perinatal death rate was significantly higher in twins, but not in singletons, born after the use of non-ejaculated sperm in comparison to twins born after the use of ejaculated sperm.
In 98% of the pregnancies established with the use of non-ejaculated sperm, fresh embryo transfer was carried out, whereas in the ejaculated group, all pregnancies were achieved after transfer of fresh embryos (OR, 0.01; 95% CI, 0.0-0.2). A significantly lower percentage of children was born after the use of fresh sperm in the non-ejaculated sperm group (60%) compared with the ejaculated sperm group (98%) (OR, 0.02; 95% CI, 0.01-0.04; Supplementary data, Table S1 ).
Although the pregnancy outcome is beyond the scope of this study, the overall birth rate was significantly lower in the non-ejaculated sperm group compared with the ejaculated sperm group (Supplementary data, Table S1 ).
Parental characteristics
Maternal characteristics in the non-ejaculated and the ejaculated sperm groups were comparable for maternal age (mean + SD: 31.9 + 4.6 versus 32.2 + 4.2 years; P ¼ 0.14), nulliparity rate (74.6 versus 77.3%; OR, 0.8; 95% CI, 0.7-1.1), high educational level (56.5 versus 51%; OR, 1.2; 95% CI, 0.9-1.6) and pregnancy-induced conditions (12.2 versus 11.6%; OR, 1.1; 95% CI, 0.8 -1.4). Mothers pregnant after the use of non-ejaculated sperm more frequently smoked during their pregnancy compared with those pregnant after the use of ejaculated sperm (11.4 versus 6.1%; OR, 2.0; 95% CI, 1.2-3.1). In 287 pregnancies after the use of non-ejaculated sperm, karyotyping of the mother was performed in our department, with 
Neonatal characteristics
Clinical data were available at 2 months of age, from, respectively, 488 (93%) and 160 (88%) children, at 1 year from 322 and 108 children and at 2 years of age from 177 and 61 children born after the use of testicular and epididymal sperm. Both in the testicular and the epididymal sperm groups, mean birthweight, length and head circumference (Table II) as well as prematurity, low birthweight and very low birthweight rate were comparable with results in the ejaculated sperm group (Table III) .
The sex ratio [defined as % males/(males + females)] of 50.6% in the non-ejaculated sperm group was comparable to that of 50.2% in the ejaculated sperm group (OR, 1.0; 95% CI, 0.8-1.2) and to the general population in Flanders (51.4%; OR, 1.0; 95% CI, 0.9 -1.2).
Congenital anomalies
All observed major anomalies in live borns are listed in Supplementary data, Table S2 . Major anomalies were present in 5.0% (26 of 518) of the live born children conceived after the use of testicular sperm compared with 3.4% (84 of 2477; OR, 1.5; 95% CI, 0.9 -2.4) in peers born after the use of ejaculated sperm. Major anomalies in the genital tract were more frequently observed in the live born testicular sperm group (1.0%; 5 of 518) compared with the live born ejaculated sperm group (0.3%; 8 of 2477; OR, 3.0; 95% CI, 1.0-9.2) and included cryptorchid testes and hypospadias.
Overall, major anomalies and major genital anomalies were found in 4.8 and 0.7% of the ICSI live borns using non-ejaculated sperm compared with 3.4 and 0.3% in the peers born after the use of ejaculated sperm (OR, 1.4; 95% CI, 0.9 -2.2; and OR, 2.2; 95% CI, 0.7-6.8, respectively). In parallel, the total major anomaly rate was comparable between the non-ejaculated sperm group (39 of 724; 5.3%) and the ejaculated sperm group (104 of 2516; 4.1%; OR, 1.3; 95% CI, 0.9 -1.9).
Karyotype
In 195 fetuses/children born after the use of testicular sperm, karyotyping was performed (Table IV) four cases: three (1.5%) de novo abnormalities and one (0.5%) inherited abnormality from the father. In the epididymal group, karyotyping was performed in 74 fetuses/children. No de novo or inherited abnormalities were documented. A higher non-significant de novo karyotype anomaly rate was found in the non-ejaculated sperm group compared with the general population. The incidence of de novo karyotype abnormalities was comparable between the non-ejaculated and the ejaculated sperm groups. Comparable rates of inherited anomalies were found in the non-ejaculated sperm group and the general population.
Outcome measures according to the cause of azoospermia are presented in Table V .
Birthweight and gestational age in singletons and twins were comparable between the OA and the NOA groups (Table V) . Furthermore, sex ratio, de novo karyotype anomaly rate and major anomaly rate in live borns were comparable between the OA and the NOA groups.
Discussion
Neonatal data of a large cohort of 724 children born after ICSI using non-ejaculated sperm were compared with outcome data of 2516 ICSI children using ejaculated sperm, showing overall reassuring findings.
Consistent with the literature, no difference regarding birth parameters and incidence of prematurity, low birthweight and very low birthweight rates was found between the non-ejaculated and the ejaculated sperm groups (Wennerholm et al., 2000; Ludwig and Katalinic, 2003) .
Stillbirth rates, early neonatal death and perinatal death rates should be interpreted according to multiplicity. In singletons, the stillborn rate was comparable between the non-ejaculated sperm group and the reference group, but was markedly higher in comparison to the general population of Flanders, where the risk for stillbirth in singletons was estimated at 0.4% (Cammu et al., 2003) . In line with this, Wisborg et al. (2010) recently reported a stillbirth risk of 1.62% for singleton pregnancies after IVF/ICSI, which was more than four times higher than in fertile women (OR, 4.44; 95% CI, ). The underlying aetiology for this increased risk remains unclear. Moreover, stillbirth rates are difficult to compare because of lack of stratification according to multiplicity and different definitions of intrauterine death between studies; that is, death after ≥20 weeks of gestation (this study), after ≥24 weeks (Loft et al., 1999) or after ≥28 weeks of gestation (Wennerholm et al., 2000) . The stillborn rate in the non-ejaculated twin group was comparable to the rate in the ejaculated twin group and higher compared with the general population (1.5%).
All singletons in the non-ejaculated sperm group died shortly after birth because of a major anomaly that was diagnosed in utero. If the parents would have chosen to terminate the pregnancy because of the finding of a major anomaly, the early neonatal death rate would be comparable for singletons regardless the use of non-ejaculated sperm or ejaculated sperm. The finding of a comparable total major anomaly rate in the non-ejaculated and the ejaculated sperm group would not change since the total major anomaly rate takes into account major anomalies in live borns, stillborns and terminations. Furthermore, in comparing early neonatal death rates, one must remember that low early neonatal death rates were described in singletons and twins from the ejaculated sperm group, since the expected rates in the general population were estimated at 0.15 and 1.46%, respectively (Cammu et al., 2003) .
The perinatal death risk for singletons in the non-ejaculated sperm group is comparable to the risk for singletons in the ejaculated sperm group but higher compared with singletons in the general population (0.55%; Cammu et al., 2003) , which is consistent with several meta-analyses describing perinatal outcome after assisted conception (Helmerhorst et al., 2004; Jackson et al., 2004; McDonald et al., 2005) . Studies comparing the outcome of ART twin pregnancies versus spontaneous twin pregnancies report heterogeneous results (Helmerhorst et al., 2004) . In our series, the perinatal death risk was higher in twins from the non-ejaculated sperm group compared with twins from the ejaculated sperm group, but not compared with the general population (3.01%; Cammu et al., 2003) .
There was no statistically significant difference in the major anomaly rate in live borns conceived with the use of non-ejaculated sperm found in comparison to the ejaculated sperm group (OR, 1.4; 95% CI, 0.9 -2.2). The risk of major anomalies in live borns does not therefore depend on the origin of the sperm, which is in agreement with described literature data (Palermo et al., 2000; Wennerholm et al., 2000; Ludwig and Katalinic, 2003; Fedder et al., 2007; Källén et al., 2010) . The reported 4.8% major anomaly rate appears to be higher than data from other research groups. Anomaly ratios described in literature should be interpreted with caution not only because of different definitions and inclusions used (live borns only or live-, stillborns and terminations) but mainly because of less numbers of children included in the non-ejaculated sperm groups. Assuming a major anomaly rate of 3.4% in the ejaculated sperm group, 469 children are needed in the non-ejaculated sperm group in order to detect a doubled major anomaly rate, with 80% power and a significance level of 5% and hence with the described cohort of 700 ICSI children born using non-ejaculated sperm, a doubling in major anomaly risk is very unlikely. However, small increases in the major anomaly risk cannot be ruled out.
As well as only the major anomaly rate in live borns, the total major anomaly rate is also comparable between the non-ejaculated and the ejaculated sperm groups.
Whether the use of cryopreserved non-ejaculated sperm is associated with a higher major anomaly rate cannot be answered by this study, since only 1.6% of the pregnancies in the control group are established with the use of cryopreserved sperm. Nevertheless, of all major anomalies described in the non-ejaculated sperm group from our study, only 21% (6 of 28) was observed in live borns after the use of frozen non-ejaculated sperm (Supplementary data, Table S2 ).
The high incidence of hypospadias (1.6%) described by Fedder et al. in a small group of 187 boys conceived by non-ejaculated sperm could not be confirmed. Our finding of 2 boys with hypospadias requiring surgery, out of 354 (0.5%) conceived using non-ejaculated sperm, is comparable to the 0.3% in the ejaculated sperm group and to findings in the general population (Toppari et al., 2001) , which is reassuring since the occurrence of hypospadias has been associated with male infertility (Sweet et al., 1974) .
The finding of a comparable de novo anomaly rate after ICSI with non-ejaculated sperm versus ejaculated sperm in the initial cohort of this study (Bonduelle et al., 2002b) was confirmed in the extended cohort. Given the higher but statistically non-significant risk of de novo karyotype anomalies in fetuses/children born after ICSI with non-ejaculated sperm in comparison to the general population, future parents are counselled to have prenatal diagnosis performed.
Azoospermia may be caused by several conditions including genetic abnormalities. Hence, distinction and comparison of the aetiology of the azoospermia in relation to the outcome measures is an additional strength of this study. Reassuringly, no difference was found regarding the neonatal outcome measures between children of fathers with NOA or OA.
Although a higher incidence of chromosomal anomalies could be expected in the NOA group because of severe male factor infertility (Gianaroli et al., 2005) , not more children from fathers with NOA showed de novo anomalies compared with peers from fathers with OA.
Previously, a number of studies described pregnancy and birth outcome after ICSI with non-ejaculated sperm facing methodological problems (Woldringh et al., 2010) .
Here, pregnancy outcome data are replenished with clinical data from the neonatal period up to the age of 1 year in order to assess the overall health of a large cohort of children born after the use of non-ejaculated sperm. Although the ejaculated sperm cohort is born partly prior to the non-ejaculated sperm cohorts, exactly the same study protocol with identical assessments and identical definitions was applied to the three cohorts of this single centre study.
In conclusion, neonatal outcome parameters for singletons were similar in ICSI children born after the use of non-ejaculated sperm compared with a control cohort of ICSI children born after the use of ejaculated sperm. Perinatal mortality risk, but not the risk of stillbirth, was higher for twins in the non-ejaculated sperm. The overall major anomaly rate and incidence of karyotype anomalies were comparable between the non-ejaculated and the ejaculated sperm groups.
